JPX · 4967.T
Kobayashi Pharmaceutical Co., Ltd.
¥7,089+¥85 (+1.21%)
Kobayashi Pharmaceutical Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 4.05% below the high.
Loading market information…
JPX · 2931.T · JPY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
Euglena Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 29.85% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Euglena Co., Ltd.’s next earnings report is currently expected on Nov 13, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Euglena Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Euglena Co., Ltd. is a Japanese enterprise specializing in the research, development, cultivation, and marketing of microalgae. Its operations are structured around two primary divisions: Healthcare Business and Energy/Environment Business. The company manufactures and sells a variety of euglena-derived food items and cosmetics. Additionally, it offers a broad portfolio of consumer goods, such as health foods, beverages, confectionery, and sports nutrition products. Furthermore, Euglena is engaged in pioneering biofuel and environmental technologies leveraging microalgae, and it makes strategic investments in the biotechnology sector. Its merchandise is distributed through numerous retail channels, including convenience stores, pharmacies, grocery stores, beauty parlors, and various specialty retailers. The company was established in Tokyo, Japan, in 2005.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:04 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| ¥12.35B-11.19% vs estimate |
| Q3 2024 | Nov 11, 2024 | -¥6 | ¥11.98B-9.89% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥7,089+¥85 (+1.21%)
Kobayashi Pharmaceutical Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 4.05% below the high.
¥1,830+¥28 (+1.55%)
Lion Corporation’s quoted price sits in the upper half of its reported 52-week range, 5.99% below the high.
¥6,014+¥246 (+4.26%)
KOSÉ Corporation’s quoted price sits in the upper half of its reported 52-week range, 7.48% below the high.
¥2,460-¥18 (-0.73%)
I-ne Co. Ltd.’s quoted price sits in the upper half of its reported 52-week range, 0.73% below the high.
¥728-¥9 (-1.22%)
Ya-Man Ltd.’s quoted price sits in the lower half of its reported 52-week range, 13.74% below the high.
¥1,062+¥26 (+2.51%)
Cota Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 23.04% below the high.
¥755¥0 (0.0%)
Artnature Inc.’s quoted price sits in the lower half of its reported 52-week range, 17.03% below the high.
¥2,239-¥46 (-2.01%)
Waqoo Inc.’s quoted price sits in the upper half of its reported 52-week range, 10.73% below the high.
